Pricing Log in Create free account

Agios Pharmaceuticals, Inc. (AGIO) vs Zenas BioPharma, Inc. (ZBIO)

Agios Pharmaceuticals, Inc. and Zenas BioPharma, Inc. are both Biotechnology companies. Agios Pharmaceuticals, Inc. and Zenas BioPharma, Inc. are of similar size ($1.7B and $1.7B). Agios Pharmaceuticals, Inc. has the higher net margin (−264.8% vs −763.1%) and the lower return on invested capital (−75.0% vs 0.00%). Across the 15 metrics below, Agios Pharmaceuticals, Inc. leads on 10 and Zenas BioPharma, Inc. on 5.

Valuation

Metric AGIO ZBIO Biotechnology median
P/E n/m n/m 10.60
P/S 12.39 26.29 9.40
P/B 1.78 8.79 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 7.92 23.52 9.02
Earnings yield (21.63%) (33.38%) (32.88%)
Free cash flow yield (19.26%) (13.01%) (23.13%)

Profitability

Metric AGIO ZBIO Biotechnology median
Gross margin 93.81% 100.00% 68.51%
Operating margin (297.72%) (741.41%) 0.00%
Net margin (264.76%) (763.11%) 0.00%
Free cash flow margin (238.54%) (342.02%) 0.00%
Return on equity (32.95%) (265.11%) (51.96%)
Return on assets (30.44%) (108.66%) (46.06%)
Return on invested capital (75.02%) 0.00% 0.00%

Growth

Metric AGIO ZBIO Biotechnology median
Revenue growth (TTM) 214.44% — 6.76%
EPS growth (last fiscal year) (161.17%) 29.04% 29.88%
Revenue growth, 5-year CAGR (14.45%) — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric AGIO ZBIO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.69 9.42 4.97
Net debt to EBITDA 1.80 0.69 1.01

Dividend

Metric AGIO ZBIO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AGIO ZBIO Biotechnology median
Market cap 1.69b 1.69b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack